Free Trial

Barclays Boosts Canada Goose (NYSE:GOOS) Price Target to $11.00

Canada Goose logo with Retail/Wholesale background

Canada Goose (NYSE:GOOS - Free Report) had its price target boosted by Barclays from $8.00 to $11.00 in a research note released on Friday,Benzinga reports. Barclays currently has an underweight rating on the stock.

Several other research analysts also recently weighed in on the company. Wells Fargo & Company upgraded Canada Goose from an "underweight" rating to an "equal weight" rating in a research note on Wednesday, April 30th. The Goldman Sachs Group upped their price objective on shares of Canada Goose from $8.00 to $9.00 and gave the company a "sell" rating in a report on Thursday, May 22nd. Evercore ISI set a $11.00 target price on shares of Canada Goose and gave the stock an "in-line" rating in a research report on Thursday, May 22nd. Cowen reiterated a "hold" rating on shares of Canada Goose in a research report on Thursday, May 22nd. Finally, UBS Group reissued a "neutral" rating and set a $11.00 price objective (up from $8.00) on shares of Canada Goose in a report on Thursday, May 22nd. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $10.50.

Check Out Our Latest Analysis on Canada Goose

Canada Goose Stock Performance

Shares of Canada Goose stock traded up $0.04 during mid-day trading on Friday, hitting $12.55. 879,835 shares of the stock were exchanged, compared to its average volume of 896,060. Canada Goose has a 12 month low of $6.73 and a 12 month high of $14.75. The company has a 50-day simple moving average of $8.56 and a 200 day simple moving average of $9.46. The company has a market capitalization of $1.21 billion, a P/E ratio of 24.14, a P/E/G ratio of 1.00 and a beta of 1.26. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.14 and a current ratio of 2.01.

Canada Goose (NYSE:GOOS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 21st. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.17. Canada Goose had a return on equity of 22.49% and a net margin of 5.47%. The business had revenue of $266.83 million for the quarter, compared to analysts' expectations of $355.76 million. During the same quarter in the previous year, the firm earned $0.14 earnings per share. The business's revenue was up 7.4% on a year-over-year basis. Sell-side analysts anticipate that Canada Goose will post 0.7 earnings per share for the current fiscal year.

Institutional Trading of Canada Goose

Several hedge funds and other institutional investors have recently bought and sold shares of GOOS. The Manufacturers Life Insurance Company increased its stake in shares of Canada Goose by 0.7% in the first quarter. The Manufacturers Life Insurance Company now owns 5,363,960 shares of the company's stock worth $42,643,000 after buying an additional 39,012 shares during the period. Patient Capital Management LLC boosted its position in Canada Goose by 3.4% during the 4th quarter. Patient Capital Management LLC now owns 3,854,520 shares of the company's stock valued at $38,661,000 after acquiring an additional 128,133 shares in the last quarter. Timucuan Asset Management Inc. FL grew its stake in Canada Goose by 10.8% in the first quarter. Timucuan Asset Management Inc. FL now owns 1,948,240 shares of the company's stock worth $15,489,000 after purchasing an additional 189,715 shares during the period. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Canada Goose in the 4th quarter worth about $12,251,000. Finally, Scheer Rowlett & Associates Investment Management Ltd. increased its stake in shares of Canada Goose by 1.2% during the fourth quarter. Scheer Rowlett & Associates Investment Management Ltd. now owns 1,218,326 shares of the company's stock valued at $12,223,000 after purchasing an additional 14,341 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Canada Goose Company Profile

(Get Free Report)

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.

See Also

Analyst Recommendations for Canada Goose (NYSE:GOOS)

Should You Invest $1,000 in Canada Goose Right Now?

Before you consider Canada Goose, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canada Goose wasn't on the list.

While Canada Goose currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines